$7.35 Billion is the total value of Woodline Partners LP's 619 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | $42,838,476 | -10.0% | 592,756 | 0.0% | 0.58% | -8.5% | |
| LLY | LILLY ELI & CO | $36,824,583 | -6.1% | 107,229 | 0.0% | 0.50% | -4.6% | |
| CVII | CHURCHILL CAPITAL CORP VII | $19,872,362 | +1.7% | 1,959,799 | 0.0% | 0.27% | +3.4% | |
| APGB | APOLLO STRATEGIC GRWT CPTL I | $13,808,544 | +2.3% | 1,347,175 | 0.0% | 0.19% | +3.9% | |
| DMY TECHNOLOGY GROUP INC VI | $10,230,000 | +1.8% | 1,000,000 | 0.0% | 0.14% | +3.7% | ||
| PCVX | VAXCYTE INC | $9,370,000 | -21.8% | 250,000 | 0.0% | 0.13% | -20.6% | |
| TWOA | TWO | $8,269,369 | +1.0% | 813,114 | 0.0% | 0.11% | +2.7% | |
| LATAMGROWTH SPAC | $6,525,010 | +1.8% | 625,001 | 0.0% | 0.09% | +3.5% | ||
| KVSC | KHOSLA VENTURES ACQUT CO III | $6,452,355 | +2.0% | 635,700 | 0.0% | 0.09% | +3.5% | |
| VOR | VOR BIOPHARMA INC | $5,977,842 | -19.1% | 1,111,123 | 0.0% | 0.08% | -18.2% | |
| HEALTHCARE AI ACQUISITION CO | $5,736,500 | +1.9% | 550,000 | 0.0% | 0.08% | +4.0% | ||
| PRGO | PERRIGO CO PLC | $5,439,291 | +5.2% | 151,639 | 0.0% | 0.07% | +7.2% | |
| HCM ACQUISITION CO | $5,469,528 | +2.0% | 522,400 | 0.0% | 0.07% | +2.8% | ||
| CEM | CLEARBRIDGE MLP AND MIDSTRM | $5,473,961 | +90.1% | 169,106 | 0.0% | 0.07% | +89.7% | |
| CORSAIR PARTNERING CORP | $5,360,260 | +2.6% | 525,001 | 0.0% | 0.07% | +4.3% | ||
| ATHENA TECHNOLOGY ACQ CORP I | $5,125,000 | +2.0% | 500,000 | 0.0% | 0.07% | +4.5% | ||
| ELLIOTT OPPORTUNITY II CORP | $4,856,130 | +1.6% | 474,000 | 0.0% | 0.07% | +3.1% | ||
| ALTENERGY ACQUISITION CORP | $4,668,750 | +1.9% | 450,000 | 0.0% | 0.06% | +4.9% | ||
| AHREN ACQUISITION CORP | $4,424,250 | +1.7% | 425,000 | 0.0% | 0.06% | +3.4% | ||
| FIRST LT ACQUISITION GROUP Icl a | $4,108,000 | +1.0% | 400,000 | 0.0% | 0.06% | +3.7% | ||
| ARYA SCIENCES ACQUISITN CORP | $4,092,000 | +1.4% | 400,000 | 0.0% | 0.06% | +3.7% | ||
| PROJECT ENERGY REIMAGINED ACclass a ord | $3,573,500 | +1.4% | 350,000 | 0.0% | 0.05% | +4.3% | ||
| SIGNAL HILL ACQUISITION CORP | $3,633,000 | +2.2% | 350,000 | 0.0% | 0.05% | +2.1% | ||
| XPAC ACQUISITION CORPclass a ord | $3,605,909 | +1.8% | 354,215 | 0.0% | 0.05% | +4.3% | ||
| TORTOISEECOFIN ACQUISITION C | $3,387,930 | +2.7% | 331,500 | 0.0% | 0.05% | +4.5% | ||
| CARTESIAN GROWTH CORP IIclass a ord | $3,147,000 | +2.3% | 300,000 | 0.0% | 0.04% | +4.9% | ||
| INFINITE ACQUISITION CORP | $3,124,490 | +1.6% | 299,999 | 0.0% | 0.04% | +4.9% | ||
| SCULPTOR ACQUISITION CORP I | $3,129,000 | +1.7% | 300,000 | 0.0% | 0.04% | +4.9% | ||
| DP CAP ACQUISITION CORP Iclass a ord | $3,187,250 | +1.9% | 305,000 | 0.0% | 0.04% | +2.4% | ||
| GOGREEN INVESTMENTS CORP | $3,165,000 | +1.6% | 300,000 | 0.0% | 0.04% | +2.4% | ||
| CARTICA ACQUISITION CORP | $3,162,000 | +2.1% | 300,000 | 0.0% | 0.04% | +4.9% | ||
| EG ACQUISITION CORP | $3,054,000 | +2.1% | 300,000 | 0.0% | 0.04% | +5.0% | ||
| VLAT | VALOR LATITUDE ACQUISITN COR | $3,072,000 | +1.8% | 300,000 | 0.0% | 0.04% | +5.0% | |
| BERENSON ACQUISITION CORP I | $3,060,000 | +1.5% | 300,000 | 0.0% | 0.04% | +5.0% | ||
| SPRING VALLEY ACQUISTN CORPclass a ord | $3,102,000 | +2.1% | 300,000 | 0.0% | 0.04% | +2.4% | ||
| JACKSON ACQUISITION CO | $3,087,000 | +1.8% | 300,000 | 0.0% | 0.04% | +2.4% | ||
| HEALTHWELL ACQUISITION CORP | $3,043,500 | +2.4% | 300,000 | 0.0% | 0.04% | +2.5% | ||
| CONCORD ACQUISITION CORP II | $3,042,000 | +2.0% | 300,000 | 0.0% | 0.04% | +2.5% | ||
| CTR | CLEARBRIDGE MLP AND MIDSTRM | $2,943,841 | -47.8% | 101,863 | 0.0% | 0.04% | -46.7% | |
| BIOHAVEN LTD | $2,763,363 | -1.6% | 202,296 | 0.0% | 0.04% | 0.0% | ||
| KIMBELL TIGER ACQUISITION CO | $2,632,500 | +2.4% | 250,000 | 0.0% | 0.04% | +5.9% | ||
| SOUND POINT ACQUISITION CORP | $2,635,000 | +1.9% | 250,000 | 0.0% | 0.04% | +2.9% | ||
| M3 BRIGADE ACQUISITION III | $2,579,979 | +1.8% | 249,998 | 0.0% | 0.04% | +2.9% | ||
| TCVA | TCV ACQUISITION CORP | $2,560,010 | +2.4% | 250,001 | 0.0% | 0.04% | +6.1% | |
| CCVI | CHURCHILL CAPITAL CORP VI | $2,527,500 | +1.2% | 250,000 | 0.0% | 0.03% | +3.0% | |
| JUNIPER II CORP | $2,333,250 | +2.0% | 225,000 | 0.0% | 0.03% | +3.2% | ||
| POWERUP ACQUISITION CORP | $2,098,000 | +1.8% | 200,000 | 0.0% | 0.03% | +3.6% | ||
| HEARTLAND MEDIA ACQUISITION | $2,082,052 | +2.4% | 200,005 | 0.0% | 0.03% | +3.7% | ||
| FOCUS IMPACT ACQUISITION COR | $2,080,000 | +2.2% | 200,000 | 0.0% | 0.03% | +3.7% | ||
| EVE MOBILITY ACQUISITION COR | $2,087,000 | +1.3% | 200,000 | 0.0% | 0.03% | 0.0% | ||
| BATTERY FUTURE ACQUISITION C | $2,088,000 | +1.7% | 200,000 | 0.0% | 0.03% | +3.7% | ||
| ACROPOLIS INFRASTRUCTURE ACQcl a | $2,026,000 | +2.2% | 200,000 | 0.0% | 0.03% | +3.7% | ||
| CLEAN EARTH ACQUISITIONS COR | $2,050,000 | +1.5% | 200,000 | 0.0% | 0.03% | +3.7% | ||
| JAGUAR GLOBAL GROWTH CORP I | $2,078,000 | +1.7% | 200,000 | 0.0% | 0.03% | +3.7% | ||
| YTPG | TPG PACE BENEFICIAL II CORP | $1,964,000 | +1.5% | 196,989 | 0.0% | 0.03% | +3.8% | |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $2,019,244 | -37.9% | 151,028 | 0.0% | 0.03% | -37.2% | |
| OPY ACQUISITION CORP I | $2,012,000 | +0.4% | 200,000 | 0.0% | 0.03% | 0.0% | ||
| G SQUARED ASCEND II INC | $2,010,450 | +1.7% | 195,000 | 0.0% | 0.03% | +3.8% | ||
| CONCORD ACQUISITION CORP III | $1,912,892 | +1.8% | 184,464 | 0.0% | 0.03% | +4.0% | ||
| ABOS | ACUMEN PHARMACEUTICALS INC | $1,730,258 | -24.8% | 426,172 | 0.0% | 0.02% | -22.6% | |
| SHOULDERUP TECHNOLOGY ACQUIS | $1,557,000 | +1.9% | 150,000 | 0.0% | 0.02% | +5.0% | ||
| NSTD | NORTHERN STAR INVEST CORP IV | $1,510,500 | +0.2% | 150,000 | 0.0% | 0.02% | +5.0% | |
| PAPAYA GRWT OPPORTUNITY CORP | $1,555,500 | +1.7% | 150,000 | 0.0% | 0.02% | +5.0% | ||
| ATLANTIC COASTAL AQSTN CORP | $1,560,000 | +2.1% | 150,000 | 0.0% | 0.02% | +5.0% | ||
| PYROPHYTE ACQUISITION CORP | $1,575,750 | +1.7% | 150,000 | 0.0% | 0.02% | 0.0% | ||
| PROOF ACQUISITION CORP I | $1,564,500 | +2.6% | 150,000 | 0.0% | 0.02% | +5.0% | ||
| REVELSTONE CAPITAL ACQSTN CO | $1,539,000 | +2.3% | 150,000 | 0.0% | 0.02% | +5.0% | ||
| FTAC ZEUS ACQUISITION COR | $1,540,500 | +2.1% | 150,000 | 0.0% | 0.02% | +5.0% | ||
| EVERGREEN CORPORATION | $1,392,091 | +1.8% | 132,960 | 0.0% | 0.02% | +5.6% | ||
| WELSBACH TECH METALS ACQU CO | $1,297,500 | +1.8% | 125,000 | 0.0% | 0.02% | +5.9% | ||
| BEARD ENERGY TRANSITION ACQ | $1,295,625 | +1.7% | 125,000 | 0.0% | 0.02% | +5.9% | ||
| ELDN | ELEDON PHARMACEUTICALS INC | $1,219,353 | +3.5% | 516,675 | 0.0% | 0.02% | +6.2% | |
| CHENGHE ACQUISITION COclass a ord | $1,051,000 | +2.0% | 100,000 | 0.0% | 0.01% | 0.0% | ||
| ZIMMER ENERGY TRANSITION ACQ | $1,013,000 | +1.8% | 100,000 | 0.0% | 0.01% | +7.7% | ||
| RNA | AVIDITY BIOSCIENCES INC | $892,157 | -30.8% | 58,121 | 0.0% | 0.01% | -29.4% | |
| KTF | DWS MUN INCOME TR | $853,296 | +3.4% | 95,876 | 0.0% | 0.01% | +9.1% | |
| HRTX | HERON THERAPEUTICS INC | $859,510 | -39.6% | 569,212 | 0.0% | 0.01% | -36.8% | |
| KSM | DWS STRATEGIC MUN INCOME TR | $792,202 | +3.8% | 93,420 | 0.0% | 0.01% | +10.0% | |
| BULLPEN PARLAY ACQUISITION C | $729,400 | +1.8% | 70,000 | 0.0% | 0.01% | 0.0% | ||
| MOTIVE CAPITAL CORP IIcl a ord | $743,118 | +2.0% | 71,214 | 0.0% | 0.01% | 0.0% | ||
| RICE ACQUISITION CORP II | $665,275 | +0.6% | 65,000 | 0.0% | 0.01% | 0.0% | ||
| ESPR | ESPERION THERAPEUTICS INC NE | $673,864 | -74.5% | 423,814 | 0.0% | 0.01% | -74.3% | |
| ZTR | VIRTUS TOTAL RETURN FD INC | $622,332 | -1.1% | 96,113 | 0.0% | 0.01% | 0.0% | |
| BIOPLUS ACQUISITION CORP | $522,000 | +2.0% | 50,000 | 0.0% | 0.01% | 0.0% | ||
| FLAHERTY & CRUMRINE DYNAMIC | $332,818 | -2.9% | 18,327 | 0.0% | 0.01% | 0.0% | ||
| FTF | FRANKLIN LTD DURATION INCOME | $340,190 | -0.5% | 55,047 | 0.0% | 0.01% | 0.0% | |
| CAPITALWORKS EMNG MKTS ACQST | $383,001 | +0.5% | 36,898 | 0.0% | 0.01% | 0.0% | ||
| PEARL HOLDINGS ACQUISITN COR | $391,500 | +2.1% | 37,500 | 0.0% | 0.01% | 0.0% | ||
| C5 ACQUISITION CORPORATION | $260,500 | +2.3% | 25,000 | 0.0% | 0.00% | +33.3% | ||
| AP ACQUISITION CORP | $316,500 | +2.1% | 30,000 | 0.0% | 0.00% | 0.0% | ||
| RCF ACQUISITION CORP | $260,750 | +1.7% | 25,000 | 0.0% | 0.00% | +33.3% | ||
| LYEL | LYELL IMMUNOPHARMA INC | $48,946 | -32.0% | 20,740 | 0.0% | 0.00% | 0.0% | |
| DMY TECHNOLOGY GROUP INC VI*w exp 99/99/999 | $39,800 | -24.2% | 500,000 | 0.0% | 0.00% | 0.0% | ||
| OPY ACQUISITION CORP I*w exp 09/22/202 | $30,000 | +233.3% | 200,000 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 16 | Q3 2023 | 3.1% |
| LILLY ELI & CO | 16 | Q3 2023 | 2.5% |
| TELEFLEX INCORPORATED | 16 | Q3 2023 | 1.1% |
| ICU MED INC | 16 | Q3 2023 | 0.9% |
| VISHAY INTERTECHNOLOGY INC | 15 | Q3 2023 | 1.9% |
| ARROW ELECTRS INC | 15 | Q3 2023 | 1.8% |
| JOHNSON & JOHNSON | 14 | Q3 2023 | 4.1% |
| REGENERON PHARMACEUTICALS | 14 | Q3 2023 | 2.0% |
| ZIMMER BIOMET HOLDINGS INC | 14 | Q3 2023 | 1.2% |
| VIAVI SOLUTIONS INC | 14 | Q3 2023 | 1.0% |
View Woodline Partners LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ascendant Digital Acquisition Corp. III | February 10, 2023 | 1,286,000 | 4.3% |
| Senti Biosciences, Inc. | February 10, 2023 | ? | ? |
| Dynamics Special Purpose Corp. | February 11, 2022 | 2,000,000 | 8.4% |
| Eledon Pharmaceuticals, Inc. | February 11, 2022 | 685,273 | 4.8% |
| MARKETWISE, INC.Sold out | February 11, 2022 | 0 | 0.0% |
| Ascendant Digital Acquisition Corp. | February 16, 2021 | 4,008,770 | 9.7% |
| Eledon Pharmaceuticals, Inc. | February 16, 2021 | 814,756 | 5.4% |
View Woodline Partners LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G | 2024-02-12 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-10 |
View Woodline Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.